Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP486691.RAwQM3NnM8AKVNo5uoqmwTB7BquWCdDEbnjBRCx8hdg00130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP486691.RAwQM3NnM8AKVNo5uoqmwTB7BquWCdDEbnjBRCx8hdg00130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP486691.RAwQM3NnM8AKVNo5uoqmwTB7BquWCdDEbnjBRCx8hdg00130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP486691.RAwQM3NnM8AKVNo5uoqmwTB7BquWCdDEbnjBRCx8hdg00130_provenance.
- NP486691.RAwQM3NnM8AKVNo5uoqmwTB7BquWCdDEbnjBRCx8hdg00130_assertion description "[Compared with normal fibroblasts, cultured hyperapoB fibroblasts incubated with BP I, which appears to be the same protein as acylation-stimulating protein (ASP), showed 50% less stimulation of triglyceride acylation and cholesterol esterification, whereas BP II markedly stimulated cholesteryl ester formation, and BP III caused no difference in response vs normal fibroblasts.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP486691.RAwQM3NnM8AKVNo5uoqmwTB7BquWCdDEbnjBRCx8hdg00130_provenance.
- NP486691.RAwQM3NnM8AKVNo5uoqmwTB7BquWCdDEbnjBRCx8hdg00130_assertion evidence source_evidence_literature NP486691.RAwQM3NnM8AKVNo5uoqmwTB7BquWCdDEbnjBRCx8hdg00130_provenance.
- NP486691.RAwQM3NnM8AKVNo5uoqmwTB7BquWCdDEbnjBRCx8hdg00130_assertion SIO_000772 2004437 NP486691.RAwQM3NnM8AKVNo5uoqmwTB7BquWCdDEbnjBRCx8hdg00130_provenance.
- NP486691.RAwQM3NnM8AKVNo5uoqmwTB7BquWCdDEbnjBRCx8hdg00130_assertion wasDerivedFrom befree-20140225 NP486691.RAwQM3NnM8AKVNo5uoqmwTB7BquWCdDEbnjBRCx8hdg00130_provenance.
- NP486691.RAwQM3NnM8AKVNo5uoqmwTB7BquWCdDEbnjBRCx8hdg00130_assertion wasGeneratedBy ECO_0000203 NP486691.RAwQM3NnM8AKVNo5uoqmwTB7BquWCdDEbnjBRCx8hdg00130_provenance.
- befree-20140225 importedOn "2014-02-25" NP486691.RAwQM3NnM8AKVNo5uoqmwTB7BquWCdDEbnjBRCx8hdg00130_provenance.